Sirna for inhibiting expression of urate transporter 1 gene, and drug and use thereof

By designing siRNA that specifically targets the URAT1 gene, the problems of side effects, tolerability, and high dosing frequency of existing URAT1 small molecule inhibitors have been solved, achieving efficient and safe treatment for hyperuricemia.

WO2026037289A1 Publication Date: 2026-02-19BEBETTER MED INC
5 Cites 1 Cited by

Patent Information

Application Number
PCT/CN2025/114129
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-03
Filing Date
2025-08-12
Publication Date
2026-02-19

AI Technical Summary

Technical Problem

Existing URAT1 small molecule inhibitors have problems such as side effects, drug tolerance, insufficient specificity, and high dosing frequency when treating hyperuricemia, which affect treatment efficacy and patient compliance.

Method used

By using siRNA that specifically targets the URAT1 gene, and through the design of specific nucleotide sequences and modification methods, double-stranded siRNA is formed to inhibit URAT1 gene expression and reduce uric acid levels.

Benefits of technology

It improves the specificity and safety of treatment, reduces side effects, lowers the frequency of administration, and improves patient compliance.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

Disclosed in the present invention is an siRNA for inhibiting the expression of a urate transporter 1 (URAT1) gene in human cells. In the present invention, a plurality of siRNAs capable of inhibiting URAT1 expression are obtained by screening, and on this basis, appropriate modifications are performed to obtain sequences with improved target silencing ability. Drugs with the siRNAs as active ingredients are expected to be clinically applicable in the prevention and treatment of diseases related to the URAT1 target, such as gout, hyperuricemia, gouty arthritis and renal calculi.
Need to check novelty before this filing date? Find Prior Art